^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    FOG-001

    i
    Other names: FOG-001
    Associations

    News

    Trials
    Company:
    Parabilis Medicines
    Drug class:
    β-catenin inhibitor
    Related drugs:
    Associations

    News

    Trials
    9d
    FOG-001-101: FOG-001 in Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov)
    P1/2, N=480, Recruiting, Parabilis Medicines, Inc. | N=245 --> 480
    Enrollment change • Metastases
    |
    MSI (Microsatellite instability) • CTNNB1 (Catenin (cadherin-associated protein), beta 1)
    |
    Opdivo (nivolumab) • Avastin (bevacizumab) • 5-fluorouracil • oxaliplatin • Lonsurf (trifluridine/tipiracil) • leucovorin calcium • FOG-001
    over1year
    FOG-001 in Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov)
    P1/2, N=208, Recruiting, Fog Pharmaceuticals, Inc.
    New P1/2 trial • Metastases
    |
    MSI (Microsatellite instability) • MYC (V-myc avian myelocytomatosis viral oncogene homolog) • CTNNB1 (Catenin (cadherin-associated protein), beta 1)
    |
    MYC expression
    |
    FOG-001